Cronos Group Inc. (CRON)
NASDAQ: CRON · IEX Real-Time Price · USD
2.680
+0.020 (0.75%)
At close: May 3, 2024, 4:00 PM
2.700
+0.020 (0.75%)
After-hours: May 3, 2024, 6:39 PM EDT
Cronos Group Revenue
In the year 2023, Cronos Group had annual revenue of $87.24M with 0.57% growth. Revenue in the quarter ending December 31, 2023 was $23.92M with 8.54% year-over-year growth.
Revenue (ttm)
$87.24M
Revenue Growth
+0.57%
P/S Ratio
11.60
Revenue / Employee
$245,059
Employees
356
Market Cap
1.02B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
Dec 31, 2020 | 46.72M | 22.97M | 96.71% |
Dec 31, 2019 | 23.75M | 11.63M | 95.94% |
Dec 31, 2018 | 12.12M | 8.97M | 285.16% |
Dec 31, 2017 | 3.15M | 2.72M | 638.69% |
Dec 31, 2016 | 426.03K | - | - |
Dec 31, 2015 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Alignment Healthcare | 1.82B |
AtriCure | 399.25M |
MiMedx Group | 334.51M |
Canopy Growth | 248.53M |
Arcutis Biotherapeutics | 59.61M |
AbCellera Biologics | 38.03M |
Silence Therapeutics | 32.12M |
Bicycle Therapeutics | 26.98M |
CRON News
- 1 day ago - May 2024 Watchlist: Leading Canadian Cannabis Stocks Poised for Growth - MarijuanaStocks
- 2 days ago - Cannabis stocks settle down after rally on plans to reclassify pot as less dangerous - Market Watch
- 2 days ago - U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance - Market Watch
- 3 days ago - US plans to reclassify cannabis as less dangerous drug - Skynews
- 3 days ago - Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug - Reuters
- 3 days ago - US drug enforcers to ease restrictions on cannabis, AP reports - Reuters
- 3 days ago - Cannabis stocks rally as AP reports imminent rescheduling proposal by DEA - Market Watch
- 7 days ago - Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders - GlobeNewsWire